References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Rasmussen(1994)CCK,schizophrenia,andanxiety.CCK-Bantagonistsinhibittheactivityofbraindopamineneurons.Ann.N.Y.Acad.Sci.713300PMID:8185172
Heltonetal(1996)CentralnervoussystemcharacterizationofthenewcholecystokininBantagonistLY288513.Pharmacol.Biochem.Behav.53493PMID:8866946
Rasmussenetal(1992)Electrophysiologicaleffectsofdiphenylpyrazolidinonecholecystokinin-Bandcholecystokinin-Aantagonistsonmidbraindopamineneurons.J.Pharmacol.Exp.Ther.264480PMID:
Keywords:LY288513,supplier,Selective,CCK2,antagonists,Cholecystokinin2,Receptors,LY288513,CCK2,Receptor,CCK2,Receptor,TocrisBioscience